ClassID:

96076

C07F9/5352 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds with one or more P—C bonds; Organo-phosphoranes Phosphoranes containing the structure P=C-

Recent Application in this class:
#1
20230293522
2023-09-21

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

#2
20220331316
2022-10-20

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

#3
20210161869
2021-06-03

ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS

#4
20200281905
2020-09-10

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

#5
20200085821
2020-03-19

Heteroaryl compounds useful as inhibitors of SUMO activating enzyme

#6
20190314346
2019-10-17

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

#7
20180311239
2018-11-01

Heteroaryl compounds useful as inhibitors of sumo activating enzyme

#8
20180133198
2018-05-17

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

#9
20170216290
2017-08-03

Heteroaryl compounds useful as inhibitors of SUMO activating enzyme

#10
20170216263
2017-08-03

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

#11
20160031816
2016-02-04

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

#12
20140163187
2014-06-12

η:η-cyclopentadienylidene-phosphorane constrained geometry complexes of rare earth metals

#13
20140155562
2014-06-05

Homoleptic rare earth triaryl complexes

#14
20120310000
2012-12-06

Rosuvastatin calcium intermediate and method for preparing the same

#15
20110034715
2011-02-10

Cyclopentadienylphosphazene complexes (CpPN Complexes) of metals of the third and fourth group and of the lanthanoids

#16
20100160663
2010-06-24

Process for preparing intermediates of HMG-CoA reductase inhibitors

#17
20090209779
2009-08-20

Process for preparing intermediates of HMG-CoA reductase inhibitors

#18
20090076292
2009-03-19

Rosuvastatin intermediates and process for the preparation of rosuvastatin

#19
20090076271
2009-03-19

Process for preparing intermediates of HMG-CoA reductase inhibitors

#20
20080312462
2008-12-18

Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives

#21
20080274334
2008-11-06

Dry Etching Gas and Method of Dry Etching

#22
20070232814
2007-10-04

Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof

#23
20070155970
2007-07-05

PROCESS FOR THE MANUFACTURE OF HMG-COA REDUCTASE INHIBITORY MEVALONIC ACID DERIVATIVES

#24
20060223888
2006-10-05

Valproic acid analogues and pharmaceutical composition thereof

#25
20060149065
2006-07-06

Process for the preparation of rosuvastatin

#26
20050159480
2005-07-21

Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives

#27
20050080215
2005-04-14

Method for preparing polyorganosiloxanes (pos) by polycondensation/redistribution of oligosiloxanes in the presence of a strong base and strong bases used

#28
20050072686
2005-04-07

Micro-engineered reactors